Attached files
| file | filename |
|---|---|
| EX-10.23 - MB CASH CONTRIBUTION AGREEMENT - Endo International plc | ex1023mbcashcontributi.htm |
| EX-32.1 - CEO 906 CERT - Endo International plc | ex32112312019ceo906cert.htm |
| EX-31.2 - CFO 302 CERT - Endo International plc | ex31212312019cfo302cert.htm |
| EX-31.1 - CEO 302 CERT - Endo International plc | ex31112312019ceo302cert.htm |
| EX-24.1 - POWER OF ATTORNEY - Endo International plc | ex24112312019powerofat.htm |
| EX-23.1 - CONSENT OF PWC - Endo International plc | ex23112312019consentof.htm |
| EX-21.1 - 12.31.2019 SUBSIDIARIES - Endo International plc | ex21112312019subsidiar.htm |
| EX-10.24 - MB LETTER AGREEMENT - Endo International plc | ex1024mbletteragreement.htm |
| EX-10.19 - CFO AGREEMENT - Endo International plc | a1019cfoagreement.htm |
| EX-10.18.1 - CEO AGREEMENT - Endo International plc | a10181ceoagreement.htm |
| EX-4.1 - DESCRIPTION OF SECURITIES - Endo International plc | ex41descriptionofregis.htm |
| 10-K - 10-K - Endo International plc | endp-12312019x10k.htm |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Blaise Coleman, as Chief Financial Officer of Endo International plc (the Company), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Annual Report on Form 10-K of the Company for the annual period ended December 31, 2019 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/S/ BLAISE COLEMAN | |||
Name: | Blaise Coleman | ||
Title: | Executive Vice President, Chief Financial Officer (Principal Financial Officer) | ||
Date: February 26, 2020
A signed original of this written statement required by Section 906 has been provided to, and will be retained by, Endo International plc and furnished to the Securities and Exchange Commission or its staff upon request.